The Beauty Health Company carries a market capitalization of 82.15M, placing it among publicly traded companies globally. Its enterprise value stands at 275.84M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 82.15M |
| Enterprise Value | 275.84M |
The Beauty Health Company currently has 129.14M shares outstanding.
| Shares Outstanding | 129.14M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.38, and the price-to-book ratio stands at -0.22.
| PE Ratio | N/A |
| PS Ratio | 0.38 |
| PB Ratio | -0.22 |
| P/TBV Ratio | -1.09 |
| P/FCF Ratio | 3.38 |
| P/OCF Ratio | 3.91 |
On an enterprise value basis, The Beauty Health Company trades at an EV/EBITDA multiple of 19.79 and an EV/FCF ratio of 3.72.
| EV / Sales | 0.93 |
| EV / EBITDA | 19.79 |
| EV / EBIT | N/A |
| EV / FCF | 3.72 |
The Beauty Health Company maintains a current ratio of 1.79, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 664.61, indicating elevated leverage, while an interest coverage ratio of 0.60 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.79 |
| Quick Ratio | 1.45 |
| Debt / Equity | 664.61 |
| Debt / EBITDA | 26.34 |
| Interest Coverage | 0.60 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -1.06 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.83 |
| Income Tax | 2.51M |
| Effective Tax Rate | N/A |
The Beauty Health Company's stock has declined approximately -61.58182% over the past 52 weeks. The 50-day moving average sits at 0.83, while the 200-day moving average is 1.36.
| Beta (5Y) | N/A |
| 52-Week Price Change | -61.58182% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 1.36 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, The Beauty Health Company generated 296.12M in revenue and converted that into -6.05M in net income, yielding earnings per share of -0.05. EBITDA reached 13.94M, while operating income came in at -10.58M.
| Revenue | 296.12M |
| Gross Profit | 192.22M |
| Operating Income | -10.58M |
| Pretax Income | -3.55M |
| Net Income | -6.05M |
| EBITDA | 13.94M |
| EBIT | -10.58M |
| Earnings Per Share (EPS) | -0.05 |
The Beauty Health Company holds 204.36M in cash and equivalents against 367.13M in total debt, resulting in a net debt position of 139.86M. Total book value stands at -524.10M, with working capital of 122.49M providing operational flexibility.
| Cash & Cash Equivalents | 204.36M |
| Total Debt | 367.13M |
| Net Debt | 139.86M |
| Equity (Book Value) | -524.10M |
| Book Value Per Share | -4.13 |
| Working Capital | 122.49M |
The Beauty Health Company produced 28.94M in operating cash flow over the past twelve months. After subtracting -5.67M in capital expenditures, free cash flow totaled 23.27M - equivalent to 0.18 per share.
| Operating Cash Flow | 28.94M |
| Capital Expenditures | -5.67M |
| Free Cash Flow | 23.27M |
| FCF Per Share | 0.18 |
The Beauty Health Company operates with a gross margin of 64.91, reflecting its pricing power and cost economics. The operating margin of -3.57 and net profit margin of -2.04 provide insight into operational efficiency.
| Gross Margin | 64.91 |
| Operating Margin | -3.57 |
| Pretax Margin | -1.20 |
| Profit Margin | -2.04 |
| EBITDA Margin | 4.71 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 172.97 |
| FCF Yield | 29.56 |
The Beauty Health Company posts an Altman Z-Score of -0.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.87 |